NCT00587340|Completed
Loading search results
Sponsor study identifier
observational
256
1 country
1
Study Start
August 2006
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
September 2011
Actual (reported)Study Completion
September 2011
Actual (reported)The purpose of this study is to gain greater understanding of the problems breast cancer survivors experience related to difficulty sleeping and insomnia. Poor sleep can affect a person's mood, increase feelings of fatigue, as well as pain. A greater knowledge and understanding of sleep disturbances can lead to more effective treatment of sleep problems and significantly improve quality of life.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 2011
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 2006
Date type not reportedThis date has not been verified as actual or estimated.
December 21, 2007
Actual (reported)January 7, 2008
Actual (reported)September 2011
Actual (reported)September 2011
Actual (reported)Determine the prevalence of cancer-related insomnia in women surviving breast cancer (Stage I, II, & III) who are at least one year, but not more than 10 years posttreatment & to study its deleterious impact on qol
2 years
To describe the underlying physiology and nature of sleep disturbances in this cohort of women by performing sleep lab studies with a subset of the sample
2 years
To survey the medical, demographic and psychosocial correlates of cancer-related insomnia in this cohort of women to identify subgroups with potentially differing etiologies and associated symptoms to help plan relevant intervention studies
2 Years
To preliminarily describe correlations between subgroups and sleep disturbances documented in the sleep lab studies
2 years
15 subjects with subjective sleep disturbance based on the Pittsburgh Sleep Quality Index
mild/moderate subjective sleep disturbance (insomnia) based on the Pittsburgh Sleep Quality Index
severe subjective sleep disturbance (insomnia)based on the Pittsburgh Sleep Quality Index
Breast cancer Patients
Memorial Sloan Kettering Cancer Center
New York, New York, 10021, United States
Steven Passik, PhD
Memorial Sloan Kettering Cancer Center
256 participants (actual enrollment reported by the registry).
First Submitted
December 21, 2007
First Posted
January 7, 2008
Study Start
August 2006
Date type not reportedThis date has not been verified as actual or estimated.
Bicalutamide in Treating Patients With Metastatic Breast Cancer
Contact the study team to confirm eligibility.
Primary Completion
September 2011
Actual (reported)Study Completion
September 2011
Actual (reported)Last Updated
September 19, 2011
Record last verified: 2011-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: